-+ 0.00%
-+ 0.00%
-+ 0.00%

ONCOC4: CESALATAMIG MONOTHERAPY ACHIEVES 33% OBJECTIVE RESPONSE RATE, 90% DISEASE CONTROL RATE AT 10 MG/KG IN PD-(L)1-RESISTANT NSCLC

Reuters·11/06/2026 14:31:34

Please log in to view news